Table 7.
Item | Hemophilia A | Hemophilia B |
---|---|---|
Factor levels |
|
|
Obstetric clinical area | ||
Second- and third-trimester activity | Multidisciplinary consultations and labour and delivery planning are required | As for hemophilia A |
Second stage before delivery | Tranexamic acid, 1000 mg orally | |
Anesthesia |
|
|
Low level of coagulation factor (VIII/IX) | FVIII level < 0.8 IU/dL: FVIII coagulation factor replacement to achieve > 100–150 IU/dL at delivery, or desmopressin, 0.3 μg/kg (prepregnancy weight) nasally or subcutaneously after cord clamping* |
|
Delivery |
|
|
Postpartum hemorrhage | Prophylaxis therapy: coagulation factor replacement is most common therapy; desmopressin, plasma or tranexamic acid rarely used |
|
Postpartum period |
|
|
FIX = factor IX; FVIII = factor VIII.
Desmopressin is safe in the first and second trimesters, but safety at delivery has not been shown (risk of fluid overload and hyponatremia/fluid restriction). Saline use and sodium evaluation are required.